High Protein Oral Nutritional Support With Special Nutrients in Patients

Clinical Trial Description

The intervention group receive 2 x ONS drink daily (total 2 x 200 kcal, 3 g arginin, 250 ml vitamin C, 38 mg vitamin e, 64 micr.g selenium, 9 mg zink) ;

Study Design

Related Conditions & MeSH terms

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT01308177` - Efficacy of Ecabet Sodium and Proton Pump Inhibitor Combination Therapy in the Treatment of Iatrogenic Ulcer After Endoscopic Submucosal Dissection	Phase 4
Withdrawn	`NCT03211910` - Sacral Savers: Study of Prevention and Enhanced Healing of Sacral and Trochenteric Ulcers	N/A
Completed	`NCT04963829` - Unripe Banana Peel Powder and Lemongrass Oil in Chronic Ulcer	Phase 1

See also

Status

Clinical Trial

Phase

Enrolling by invitation

NCT01308177 - Efficacy of Ecabet Sodium and Proton Pump Inhibitor Combination Therapy in the Treatment of Iatrogenic Ulcer After Endoscopic Submucosal Dissection

Phase 4

Withdrawn

NCT03211910 - Sacral Savers: Study of Prevention and Enhanced Healing of Sacral and Trochenteric Ulcers

N/A

Completed

NCT04963829 - Unripe Banana Peel Powder and Lemongrass Oil in Chronic Ulcer

Phase 1

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05464407
Study type	Interventional
Source	Aalborg University Hospital
Contact
Status	Terminated
Phase	N/A
Start date	February 24, 2022
Completion date	March 31, 2023

High Protein Oral Nutritional Support With Special Nutrients in Patients With Type 2 Diabetes and Foot Ulcer

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms